Skip to main content
Premium Trial:

Request an Annual Quote

George Adam, Christopher Hibberd

Premium
Applera, the parent company of Applied Biosystems and Celera, last week named George Adam to its board, expanding it to 11 members. The move anticipates the retirement of some current board members during the next several years and a need for additional directors if Applied Biosystems and Celera are split into independent companies, each with its own board, Applera said in a statement.
 
In early August, Applera said that it had retained Morgan Stanley to explore alternatives to its current corporate tracking stock structure, including possibly spinning out the two companies [See PM 08/09/07].
 

 

Oxford Genome Sciences this week said Christopher Hibberd has joined its board. Hibberd is currently CEO of Astute Medical. Prior to that, he was senior vice president of corporate development at Biosite where he was responsible for identifying and pursuing strategic business opportunities.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.